BRK-B vs GOF
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
The fund exhibits critical financial weakness with a Piotroski F-Score of 1/9, indicating severe deterioration in fundamental health. While the current price of $11.36 sits slightly below the growth-based intrinsic value of $12.11, this marginal discount is offset by an unsustainable dividend payout ratio of 126.31%. Technical trends are purely bearish (0/100), and the 1-year price performance is negative. Overall, the high yield appears to be a value trap given the underlying health metrics and negative price momentum.
Compare Another Pair
Related Comparisons
BRK-B vs GOF: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Guggenheim Strategic Opportunities Fund (GOF) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.